WallStSmart

Goodrx Holdings Inc (GDRX)vsTempus AI, Inc. Class A Common Stock (TEM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Tempus AI, Inc. Class A Common Stock generates 73% more annual revenue ($1.36B vs $787.89M). GDRX leads profitability with a 2.6% profit margin vs -22.2%. GDRX earns a higher WallStSmart Score of 35/100 (F).

GDRX

Avoid

35

out of 100

Grade: F

Growth: 2.7Profit: 5.0Value: 4.7Quality: 4.5
Piotroski: 4/9Altman Z: 0.20

TEM

Avoid

31

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 5.0Quality: 5.5
Piotroski: 4/9Altman Z: -0.66

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GDRX1 strengths · Avg: 8.0/10
Price/BookValuation
1.6x8/10

Reasonable price relative to book value

TEM1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
36.1%10/10

Revenue surging 36.1% year-over-year

Areas to Watch

GDRX4 concerns · Avg: 2.8/10
Market CapQuality
$897.49M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
3.3%3/10

ROE of 3.3% — below average capital efficiency

Profit MarginProfitability
2.6%3/10

2.6% margin — thin

P/E RatioValuation
44.2x2/10

Premium valuation, high expectations priced in

TEM4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Debt/EquityHealth
1.963/10

Elevated debt levels

Price/BookValuation
20.0x2/10

Trading at 20.0x book value

Return on EquityProfitability
-72.7%2/10

ROE of -72.7% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : GDRX

The strongest argument for GDRX centers on Price/Book.

Bull Case : TEM

The strongest argument for TEM centers on Revenue Growth. Revenue growth of 36.1% demonstrates continued momentum.

Bear Case : GDRX

The primary concerns for GDRX are Market Cap, Return on Equity, Profit Margin. A P/E of 44.2x leaves little room for execution misses. Thin 2.6% margins leave little buffer for downturns.

Bear Case : TEM

The primary concerns for TEM are EPS Growth, Debt/Equity, Price/Book. Debt-to-equity of 1.96 is elevated, increasing financial risk.

Key Dynamics to Monitor

GDRX profiles as a value stock while TEM is a hypergrowth play — different risk/reward profiles.

TEM is growing revenue faster at 36.1% — sustainability is the question.

GDRX generates stronger free cash flow (11M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

GDRX scores higher overall (35/100 vs 31/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Goodrx Holdings Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

GoodRx Holdings, Inc. provides information and tools that allow consumers to compare prices and save when buying prescription drugs in the United States. The company is headquartered in Santa Monica, California.

Visit Website →

Tempus AI, Inc. Class A Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.

Visit Website →

Want to dig deeper into these stocks?